Mongan NP - Search Results

1

Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.

Harris AE, Metzler VM, Lothion-Roy J, Varun D, Woodcock CL, Haigh DB, Endeley C, Haque M, Toss MS, Alsaleem M, Persson JL, Gudas LJ, Rakha E, Robinson BD, Khani F, Martin LM, Moyer JE, Brownlie J, Madhusudan S, Allegrucci C, James VH, Rutland CS, Fray RG, Ntekim A, de Brot S, Mongan NP, Jeyapalan JN. Harris AE, et al. Among authors: mongan np. Front Endocrinol (Lausanne). 2022 Oct 3;13:1006101. doi: 10.3389/fendo.2022.1006101. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36263323 Free PMC article. Review.

2

Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer.

Boorjian S, Tickoo SK, Mongan NP, Yu H, Bok D, Rando RR, Nanus DM, Scherr DS, Gudas LJ. Boorjian S, et al. Among authors: mongan np. Clin Cancer Res. 2004 May 15;10(10):3429-37. doi: 10.1158/1078-0432.CCR-03-0756. Clin Cancer Res. 2004. PMID: 15161698

3

Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.

Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS. Boorjian S, et al. Among authors: mongan np. Urology. 2004 Aug;64(2):383-8. doi: 10.1016/j.urology.2004.03.025. Urology. 2004. PMID: 15302512

4

Retinoid receptor mRNA expression profiles in human bladder cancer specimens.

Boorjian S, Scherr DS, Mongan NP, Zhuang Y, Nanus DM, Gudas LJ. Boorjian S, et al. Among authors: mongan np. Int J Oncol. 2005 Apr;26(4):1041-8. Int J Oncol. 2005. PMID: 15754000

5

Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells.

Mongan NP, Gudas LJ. Mongan NP, et al. Mol Cancer Ther. 2005 Mar;4(3):477-86. doi: 10.1158/1535-7163.MCT-04-0079. Mol Cancer Ther. 2005. PMID: 15767557

6

Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.

Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ. Raman JD, et al. Among authors: mongan np. Carcinogenesis. 2006 Mar;27(3):499-507. doi: 10.1093/carcin/bgi299. Epub 2005 Dec 12. Carcinogenesis. 2006. PMID: 16344273

7

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.

Raman JD, Mongan NP, Tickoo SK, Boorjian SA, Scherr DS, Gudas LJ. Raman JD, et al. Among authors: mongan np. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8570-6. doi: 10.1158/1078-0432.CCR-05-1047. Clin Cancer Res. 2005. PMID: 16361539

8

The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures.

Mongan NP, Martin KM, Gudas LJ. Mongan NP, et al. Mol Carcinog. 2006 Dec;45(12):887-900. doi: 10.1002/mc.20186. Mol Carcinog. 2006. PMID: 16865673

9

Diverse actions of retinoid receptors in cancer prevention and treatment.

Mongan NP, Gudas LJ. Mongan NP, et al. Differentiation. 2007 Nov;75(9):853-70. doi: 10.1111/j.1432-0436.2007.00206.x. Epub 2007 Jul 18. Differentiation. 2007. PMID: 17634071 Review.

10

Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma.

Boorjian SA, Milowsky MI, Kaplan J, Albert M, Cobham MV, Coll DM, Mongan NP, Shelton G, Petrylak D, Gudas LJ, Nanus DM. Boorjian SA, et al. Among authors: mongan np. J Immunother. 2007 Sep;30(6):655-62. doi: 10.1097/CJI.0b013e31805449a8. J Immunother. 2007. PMID: 17667529 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page